In vitro 3D cell culture models have emerged as a bridge between traditional 2D cell culture and in vivo animal models. With the advancement of 3D cell culture technologies, both healthy physiological models and disease states can be emulated in vitro. In this session, Dr. Lim Sei Hien from AIM Biotech will introduce the organ-on-chip solution that AIM Biotech offers and discuss how the Opentrons OT-2 helps to scale up assays for drug discovery and cell biology research.
Sign up to watch this 45-minute webinar to learn about:
Who Should Watch:
Subject to your consent given above, by clicking on "GET THE WEBINAR", Opentrons and AIM Biotech may share your personal information to communicate with you for marketing purposes, including information about this topic, promotional offers and news. This use of your personal information is an exception to our Privacy Policy.
Applications Development Manager, AIM Biotech
Lim Sei Hien is the Applications Development Manager at AIM Biotech. Prior to joining AIM Biotech’s Team, he focused on developing neovascularization strategies for tissue repair and regeneration. Sei Hien has a wealth of experience in establishing cell-based functional models in microfluidics for research applications. Sei Hien received his Ph.D. in Bioengineering from the National University of Singapore.
Originally Aired 11/14/22
Get regular updates on our latest products and newest educational articles.